Laurie D. Stelzer
2018
Compensation breakdown
| Non-Equity Incentive Plan | $323,489 |
|---|---|
| Option Awards | $575,009 |
| Salary | $470,000 |
| Stock Awards | $575,018 |
| Other | $9,409 |
| Total | $1,952,925 |
Stelzer received $575K in stock awards, accounting for 29% of the total pay in 2018.
Stelzer also received $323.5K in non-equity incentive plan, $575K in option awards, $470K in salary and $9.4K in other compensation.
Rankings
In 2018, Laurie D. Stelzer's compensation ranked 5,876th out of 14,244 executives tracked by ExecPay. In other words, Stelzer earned more than 58.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,876 out of 14,244 | 59th |
Division Manufacturing | 2,228 out of 5,759 | 61st |
Major group Chemicals And Allied Products | 828 out of 2,122 | 61st |
Industry group Drugs | 691 out of 1,811 | 62nd |
Industry Biological Products, Except Diagnostic Substances | 136 out of 339 | 60th |
Pay ratio
| Laurie D. Stelzer's Pay | $1,952,925 |
|---|---|
| Median Employee's Pay | $199,899 |
| Pay Ratio | 10to 1 |
In 2018, the annual total compensation of Laurie D. Stelzer was $1,952,925.
The annual total compensation of the median employee at Halozyme Therapeutics was $199,899.
The ratio of Laurie D. Stelzer's pay to the pay of median employee was therefore 10 to one.
Stelzer's colleagues
We found four more compensation records of executives who worked with Laurie D. Stelzer at Halozyme Therapeutics in 2018.